Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Post-Acute COVID-19 Syndrome
Open-data reference.
12 US clinical trials · 7 currently recruiting
Active & Recent Trials
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Brain Inflammation Collaborative
NCT04806620
Long-Covid-19 Alleviation Through Learning Mindfulness Study
Columbia University
NCT07140094
Care for Veterans Post-COVID-19
VA Office of Research and Development
NCT05787379
Dietary Intervention to Mitigate Post-Acute COVID-19 Syndrome
University of Maryland, Baltimore
NCT05977179
Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS
Vanderbilt University Medical Center
NCT07189936
Brain-Training Treatment for Long COVID in Older Adults
UConn Health
NCT05705193
Long COVID Brain Fog: Cognitive Rehabilitation Trial
University of Alabama at Birmingham
NCT06095297
A Study of Positive Emotions With Long COVID-19
University of California, Davis
NCT05676008
Probiotic Use for Recovery Enhancement From Long COVID-19
Rush University Medical Center
NCT06643299
Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction
University of North Carolina, Chapel Hill
NCT06204432
Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data
Pfizer
NCT05876377
Humanity Neurotech Device Clinical Trial in Adults With Long COVID Cognitive Dysfunction
Icahn School of Medicine at Mount Sinai
NCT06739668
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Post-Acute COVID-19 Syndrome Trial Landscape
ClinicalTrials.gov lists 12 US studies indexed under Post-Acute COVID-19 Syndrome, and 7 of those are currently open to recruitment — roughly 58% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Post-Acute COVID-19 Syndrome shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 3 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Post-Acute COVID-19 Syndrome is led by Brain Inflammation Collaborative with 1 indexed trial, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 12 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Post-Acute COVID-19 Syndrome?
PlainTrial tracks 12 US clinical trials for Post-Acute COVID-19 Syndrome, of which 7 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Post-Acute COVID-19 Syndrome?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.